Lack of aggregation and utilization of structured data on human processes for the fiscal and physiological benefit of each individual in society which detriments the use of AI in studying humans.
A social trial app, clinical trials as a social medium, leveraging the proliferation of individual involvement in social media to obtain data on self administered trials while compensating users.
This is the total amount allocated to of Nectar: Social Trials.
The outcome of our proposed solution is a mobile/web app with AI services that allows users to join & create studies that users around the world can participate in. Users maintain ownership over their data and can license their data for 1) fiscal stimulus, and 2) track their progress towards a specific objective, and 3) participate in a global research initiative to drive human health insight. These goals are furthered through connecting to external data sources including Sensor based apis, genetic data, etc, that can make study data more valuable to research institutions globally.
We are interested in the data generating process surrounding human involvement in “intervention” events and their health effects. Our technological innovation will be a “social trial” platform, i.e. clinical trials as a social medium. Clinical trials are often the defacto standard when studying health effects in humans. These social “trials” will take advantage of the proliferation of individual involvement in social media to obtain diverse and extensive data on human self administered trials, this real-time aggregation of user data, manual and sensor based inputs, will generate fiscal stimulus for the user through a market value system, will be used to train/deploy a proprietary real-world applicable artificial intelligences for health discovery, and allow research organizations/individuals unparalleled access to information on health processes, while motivating creative, and evolving, efforts to understand fundamental health relationships for each individual and the world.
Our Value proposition is that through the adoption of this innovative approach, and technology, people will be able to jointly benefit their fiscal, and health, profiles individually, while also contributing to further knowledge, and scope, of research into humans globally and pushing forward the adoption of Cardano. Non-geographical based clinical studies through user driven data will scale research with the number of users, and studies, as research reaches a broader scope of individuals, and wider set of social trials hypotheses. Our Objective is achievable through innovation in applying a scalable AI network that allows for the application of deep learning to sparse, subjective, and bias-potentialed data, where up to this point most clinical studies are analyzed through relatively linear, low utility statistics with low out of sample predictability, and relatively small sample sizes. The problem with using deep learning in this setting has traditionally been that of a “black box” in decision inference, and that training models require large compute, constant retraining and testing, and enough quality data for deployment into commercial applications, that we solve through a curated use of our platform’s generated IP.
Our perspective on the utilization of the Cardano network within our framework is one where the user would be able to collect their rewards from from data licensing agreements via Cardano wallets such as Yoro.
Adequate adoption of the proposed solution would constitute a huge win for Cardano's ecosystem as individuals globally become aware of/participate in the real world adoption of Cardano as it gets ingrained into everyday living while servicing under-researched aspects of how blockchain technology can improve the physiological/fiscal health of each individual.
Further, this proposal is exposed to "governance systems" as governments can license data from its populous to understand the health outcomes of its peoples while providing a likeness of universal basic income to each person through the licensing fee.
The overall reach of our proposed solution is one that truly integrates Cardano as a payment system to vast population base with implications to truly create a world where Cardano is utilized and accessed by large proportions of global populations.
Adoption risk will be the main barrier to success. However there are development barriers that are introduced through the strategy of mobile first prioritization that will require collaboration.
This will be mitigated through distribution efforts such as partnering with hospitals, universities, gyms, local governments (where applicable), and institutions to give them a platform to study the effect of various interventions on health outcomes.
This is a One Year project proposal:
BUDGET
See below response
TIMELINE
Month 1:
Month 3:
Month 6:
Month 9:
Month 12:
MILESTONES
Development
Flutter App that has base functionality for users to join/create studies according to arbitrary specifications.
Add main interactive dashboard that tracks user data for self study.
Allow data dumps from individuals / institutions.
Embed pricing algorithm for licensing fees into application.
Enable licensing payments to users per the pricing algorithm and market demand via cardano blockchain.
Enable peer-to-peer search and consultation functionality. This allows users to pay for consultations from other users who are similar (by some feature vector of stored data) and have achieved an objective that the requestee needs advice on.
Research
Curate applicable clinical trial datasets.
Create research codebase for the evaluation of advanced statistical models that leverage complex clinical trial interactions against traditional statistical models used in clinical trial inference. (tree based models, elastic net, lars, etc).
All numbers are USD.
Salaries
Research - 22,002
Development - 22,002
Management - 6,001
All funds raised will go towards employing a suite of researchers, developers, and principal investigators for the course of one year. After which further funding, from any source, will be considered for further work/marketing.
Contractor (MD)
Internationally renowned clinical and translational investigator, who is recognized for many scientific contributions, including within the field of Reproductive Endocrinology and Infertility. His contributions include publications of over 510 peer reviewed manuscripts, 135 chapters, and 825 abstracts. He has been funded by six NIH Institutes, including NICHD to conduct randomized clinical trials utilizing the euglycemic, hyperinsulinemic clamp and hyperglycemic clamp techniques to evaluate the role of androgens on insulin sensitivity in men and women.
His knowledge will be utilized to make sure we adhere to research and government based standards when dealing with human data.
Flutter/Blockchain Developers
Experience developing web/mobile applications for US based institutions. This team is responsible for developing the application Front/Back ends and deploying the app to apple/google store for mass adoption.
Researchers
A team of researchers with experiences spanning ML applications in Biology and Systematic Trading.
This team will be responsible for developing a structured protocol for efficient data processing, information retrieval, as well as the AI model architecture and training.
It is likely that to fully succeed in development we will need multiple rounds of funding to properly scale, however fund9 will be adequate in procuring a mvp which can be used to secure funding through other avenues such as VC, NIH, social funding, etc.
Auditability will be measured per team through the following KPIs:
Research
Development
Management
Creating a dapp platform that:
No
Edward Diamond
MSc in STEM from Washington University in St Louis
BA in Finance from Michigan State
Experience includes quant research for large global corporations that where advanced statistical models are employed to decompose asset price processes.